Literature DB >> 31468281

A Novel Homozygous Missense Variant in the NAGA Gene with Extreme Intrafamilial Phenotypic Heterogeneity.

Fedah E Mohamed1, Mohammad Al Sorkhy2, Mohammad A Ghattas2, Nuha Al-Zaabi3,4, Aisha Al-Shamsi4, Taleb M Almansoori5, Lihadh Al-Gazali3, Osama Y Al-Dirbashi3, Fatma Al-Jasmi6,7, Bassam R Ali8.   

Abstract

Schindler disease is a rare autosomal recessive lysosomal storage disorder caused by a deficiency in alpha-N-acetylgalactosaminidase (α-NAGA) activity due to defects in the NAGA gene. Accumulation of the enzyme's substrates results in clinically heterogeneous symptoms ranging from asymptomatic individuals to individuals with severe neurological manifestations. Here, a 5-year-old Emirati male born to consanguineous parents presented with congenital microcephaly and severe neurological manifestations. Whole genome sequencing revealed a homozygous missense variant (c.838C>A; p.L280I) in the NAGA gene. The allele is a reported SNP in the ExAC database with a 0.0007497 allele frequency. The proband's asymptomatic sister and cousin carry the same genotype in a homozygous state as revealed from the family screening. Due to the extreme intrafamilial heterogeneity of the disease as seen in previously reported cases, we performed further analyses to establish the pathogenicity of this variant. Both the proband and his sister showed abnormal urine oligosaccharide patterns, which is consistent with the diagnosis of Schindler disease. The α-NAGA activity was significantly reduced in the proband and his sister with 5.9% and 12.1% of the mean normal activity, respectively. Despite the activity loss, p.L280I α-NAGA processing and trafficking were not affected. However, protein molecular dynamic simulation analysis revealed that this amino acid substitution is likely to affect the enzyme's natural dynamics and hinders its ability to bind to the active site. Functional analysis confirmed the pathogenicity of the identified missense variant and the diagnosis of Schindler disease. Extreme intrafamilial clinical heterogeneity of the disease necessitates further studies for proper genetic counseling and management.

Entities:  

Keywords:  Alpha-N-acetylgalactosaminidase; Congenital microcephaly; Enzymatic activity; NAGA gene; Schindler disease; Whole genome sequencing

Mesh:

Substances:

Year:  2019        PMID: 31468281     DOI: 10.1007/s12031-019-01398-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  A new case of alpha-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with Ménière's syndrome and without mental retardation.

Authors:  K Kodama; H Kobayashi; R Abe; A Ohkawara; N Yoshii; S Yotsumoto; T Fukushige; Y Nagatsuka; Y Hirabayashi; T Kanzaki
Journal:  Br J Dermatol       Date:  2001-02       Impact factor: 9.302

2.  ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.

Authors:  Idit Ron; Mia Horowitz
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

3.  Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: no association with neuroaxonal dystrophy?

Authors:  H D Bakker; M L de Sonnaville; P Vreken; N G Abeling; J E Groener; J L Keulemans; O P van Diggelen
Journal:  Eur J Hum Genet       Date:  2001-02       Impact factor: 4.246

4.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

5.  The molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes angiokeratoma corporis diffusum with glycopeptiduria.

Authors:  A M Wang; T Kanzaki; R J Desnick
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

6.  Exploration of Structural and Functional Variations Owing to Point Mutations in α-NAGA.

Authors:  D Meshach Paul; R Rajasekaran
Journal:  Interdiscip Sci       Date:  2016-05-02       Impact factor: 2.233

7.  The molecular defect leading to Fabry disease: structure of human alpha-galactosidase.

Authors:  Scott C Garman; David N Garboczi
Journal:  J Mol Biol       Date:  2004-03-19       Impact factor: 5.469

8.  Human Gene Mutation Database (HGMD): 2003 update.

Authors:  Peter D Stenson; Edward V Ball; Matthew Mort; Andrew D Phillips; Jacqueline A Shiel; Nick S T Thomas; Shaun Abeysinghe; Michael Krawczak; David N Cooper
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

9.  alpha-N-acetylgalactosaminidase deficiency, a new lysosomal storage disorder.

Authors:  O P van Diggelen; D Schindler; R Willemsen; M Boer; W J Kleijer; J G Huijmans; W Blom; H Galjaard
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.